Risk of Stroke and Incident Atrial Fibrillation in Patients in Sinus Rhythm With Nonischemic Dilated Cardiomyopathy

• Published in: The American journal of cardiology Vol. 233; pp. 11 - 18
• Main Authors: Ródenas-Alesina, Eduard, Lozano-Torres, Jordi, Tobías-Castillo, Pablo Eduardo, Badia-Molins, Clara, Calvo-Barceló, Maria, Vila-Olives, Rosa, Casas-Masnou, Guillem, San Emeterio, Aleix Olivella, Soriano-Colomé, Toni, Fernández-Galera, Rubén, Méndez-Fernández, Ana B., Barrabés, José A., Rodríguez-Palomares, José, Ferreira-González, Ignacio
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 15-12-2024; Elsevier Limited
• Subjects: atrial fibrillation; Cardiac arrhythmia; Cardiomyopathy; Cardiovascular disease; Confidence intervals; Deformation analysis; Diabetes; Dilated cardiomyopathy; Fibrillation; Health risks; Heart; heart failure; Hypertension; Ischemia; Laboratories; left atrial function; left atrial volume index; non-ischemic dilated cardiomyopathy; Pulmonary arteries; Reclassification; Rhythm; Risk analysis; Sinuses; Software; Statistical analysis; Stroke; Survival analysis; Thromboembolism; Variables; United States > US; Texas; heart failure; non-ischemic dilated cardiomyopathy; atrial fibrillation; left atrial volume index; stroke; left atrial function
• ISSN: 0002-9149; 1879-1913; 1879-1913
• DOI: 10.1016/j.amjcard.2024.09.024

Nonischemic dilated cardiomyopathy (NIDCM) is associated with an increased risk of atrial fibrillation (AF) and stroke, especially in patients with high CHA2DS2-VASc. We aimed to identify variables associated with incident AF or stroke using left atrial deformation analysis and its prognostic value added to CHA2DS2-VASc score. Patients with NIDCM and left ventricular ejection fraction <50% in sinus rhythm were included between January 2015 and December 2019. Left atrial volume index (LAVI) and atrial strain were used in combination with the CHA2DS2-VAS score to predict ischemic stroke or incident AF. Proportional hazards Cox regression was used to provide hazard ratios (HRs). There were 338 patients included. After a median follow-up of 3.6 years, the end point occurred in 41 patients (12.1%). LAVI outperformed other echocardiographic parameters, with a significant improvement in risk reclassification compared with CHA2DS2-VASc alone (net reclassification index 0.6, increase in Harrell's C from 0.63 to 0.73, p = 0.003), and remained significant after multivariate adjustment. LAVI was associated with both components of the end point separately. The best cutoff for LAVI was 44 ml/m2. LAVI ≥44 ml/m2 increased the risk of the end point among those with CHA2DS2-VASc ≥3 (HR 6.0, 95% confidence interval 2.6 to 13.5) but not in those with CHA2DS2-VASc <3 (HR 1.2, 95% confidence interval 0.3 to 4.5). Competing risk analysis did not alter the results. In conclusion, LAVI might be used to assess the risk of incident AF or stroke in NIDCM. Patients with LAVI ≥44 ml/m2 and CHA2DS2-VASc ≥3 could be at high risk of AF and stroke and may benefit from more intensive surveillance.
[Display omitted]